Telix Pharmaceuticals | TLX - Debt

Stock Price
10.00
Daily Change
-0.20 -1.96%
Monthly
-14.16%
Yearly
-64.86%
Q1 Forecast
10.21

Telix Pharmaceuticals reported AUD418.25M in Debt for its fiscal semester ending in June of 2025.





Debt Change Date
Cochlear AUD 235.7M 10.9M Jun/2025
CSL USD 11.96B 219M Dec/2024
Integral Diagnostics AUD 357.8M 3.7M Jun/2024
Mayne Pharma AUD 38.82M 2.24M Jun/2024
Medical Developments International AUD 1.99M 152K Jun/2025
Mesoblast USD 128.16M 9.23M Jun/2025
Neuren Pharmaceuticals AUD 0 0 Dec/2024
Pacific Edge NZD 2.9M 425K Mar/2025
Paradigm Biopharmaceuticals AUD 181.4K 38.99K Dec/2024
Polynovo AUD 15.38M 49K Jun/2024
PYC Therapeutics AUD 1.02M 185.07K Jun/2025
Ramsay Health Care AUD 12.12B 864.4M Jun/2025
ResMed USD 846.35M 5.46M Sep/2025
Sonic Healthcare AUD 4.8B 282.9M Dec/2024